References
- The Johns Hopkins University of Medicine. COVID-19 dashboard by the
Center for Systems Science and Engineering at Johns Hopkins
University. https://coronavirus.jhu.edu/map.html Date accessed:
November 22, 2020
- Sanyaolu, A., Okorie, C., Marinkovic, A. et al. Comorbidity and
its Impact on Patients with COVID-19. SN Compr. Clin.
Med. 2, 1069–1076 (2020).
https://doi.org/10.1007/s42399-020-00363-4.
- Hasan Ejaz, Abdullah Alsrhani, Aizza Zafar, Humera Javed, Kashaf
Junaid, Abualgasim E. Abdalla, Khalid O.A. Abosalif, Zeeshan Ahmed,
Sonia Younas, COVID-19 and comorbidities: Deleterious impact on
infected patients, Journal of Infection and Public Health.
2020;[Pre-print] DOI: 10.1016/j.jiph.2020.07.014
https://doi.org/10.1016/j.jiph.2020.07.014.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu
X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B.
Clinical course and risk factors for mortality of adult inpatients
with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet
2020;395:1054-62.
- Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its
receptor damages islets and causes acute diabetes. Acta Diabetol 2010
Sep;47:193e9.
doi: 10.1007/s00592-009-0109-4
- Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell2020; 181 (2): 271–280.
https://doi.org/10.1016/j.cell.2020.02.052.
- Fadini, G.P., Morieri, M.L., Longato, E. et al. Prevalence and
impact of diabetes among people infected with SARS-CoV-2. J
Endocrinol Invest . 2020; 43, 867–869.
https://doi.org/10.1007/s40618-020-01236-2.
- Rimesh Pal, Sanjay K. Bhadada, COVID-19 and diabetes mellitus: An
unholy interaction of two pandemics, Diabetes & Metabolic Syndrome:
Clinical Research & Reviews, 2020; 14(4): 513-517
https://doi.org/10.1016/j.dsx.2020.04.049.
- Hollstein, T., Schulte, D.M., Schulz, J. et
al. Autoantibody-negative insulin-dependent diabetes mellitus after
SARS-CoV-2 infection: a case report. Nat
Metab 2, 1021–1024 (2020).
https://doi.org/10.1038/s42255-020-00281-8.
- Hadil A A O, Eman S, Bashayer Zuhair A S, Anwar J. Diabetic
Ketoacidosis and New Onset Diabetes Mellitus Precipitated by COVID-19
Infection. JOJ Case Stud. 2020; 11(3): 555815.
DOI 10.19080/JOJCS.2020.11.555815.
- Thirunavukkarasu Sathish, Yingting Cao, Nitin Kapoor, Newly diagnosed
diabetes in COVID 19 patients, Primary Care
Diabetes, 10.1016/j.pcd.2020.08.014, (2020).
https://doi.org/10.1002/jmv.26339
- Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim
J. Clinical characteristics and outcome in patients with combined
diabetic ketoacidosis and hyperosmolar hyperglycemic state associated
with COVID-19: A retrospective, hospital-based observational case
series. Diabetes Res Clin Pract . 2020;166:108279.
doi:10.1016/j.diabres.2020.108279.
- Rimesh Pal, Mainak Banerjee, Urmila Yadav, Sukrita Bhattacharjee,
Clinical profile and outcomes in COVID-19 patients with diabetic
ketoacidosis: A systematic review of literature, Diabetes & Metabolic
Syndrome: Clinical Research & Reviews, 2020; 14(6): 1563-1569
https://doi.org/10.1016/j.dsx.2020.08.015.
- Armeni E, Aziz U, Qamar S, Nasir S, Nethaji C, Negus R, Beynon H.C,
Bouloux P, Rosenthal M, Khan S, Yousseif A and Menon.
Protracted
ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective
case series. Lancet Diabetes Endocrinol . 2020;8(8): 660-663.
https://doi.org/10.1016/S2213-8587(20)30221-7.